Teva Pharmaceuticals USA, Inc. — WIPO D2016-1110

WIPO Case No. D2016-1110 (Aug. 2016)

Case

WIPO Case No. D2016-1110 (Aug. 2016)

Decision date

2016-08-15

Outcome

1 transferred

Policy

UDRP

Scope

Related fraud or OSINT

Public attribution

Matkowsky Law named

Evidence summary

Registration followed a fresh GLYFEX filing; evidence of similar conduct involving VELIMOND.

Panel finding

Panel accepted anticipatory registration and a pattern of conduct.

Qualification

Chinese-language decision; timing argument was contested. One disputed domain.

Domains adjudicated

1 domain adjudicated: glyfex.com

Source and provenance

This page is a Matkowsky.com case record derived from the verified published decision and controlled corpus metadata. The official provider decision remains the authoritative source and is retained as provenance; this site does not send visitors to the provider decision unless a visitor specifically asks for that official link.